115
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Inhibiting the Jumonji Family: A Potential New Clinical Approach to Targeting Aberrant Epigenetic Mechanisms

&
Pages 313-316 | Received 07 Dec 2015, Accepted 08 Dec 2015, Published online: 26 Feb 2016
 

Financial & competing interests disclosure

This work was partly funded by the NIH (R01 CA125269 to ED Martinez; R21 AI116222 to ED Martinez), by the Friends of the Cancer Center, by The Welch Foundation (I-1878 to ED Martinez), and by CPRIT (RP120717). Funding was also provided by the Texas Specialized Program of Research Excellence in Lung Cancer (P50CA70907) from the National Cancer Institute, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

This work was partly funded by the NIH (R01 CA125269 to ED Martinez; R21 AI116222 to ED Martinez), by the Friends of the Cancer Center, by The Welch Foundation (I-18 78 to ED Martinez), and by CPRIT (RP120717). Funding was also provided by the Texas Specialized Program of Research Excellence in Lung Cancer (P50CA70907) from the National Cancer Institute, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.